Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Detection and Isolation of C. difficile Asymptomatic Carriers during C. difficile Infection Outbreaks - an Exploratory Study.

Paquet-Bolduc B, Gervais P, Roussy JF, Trottier S, Oughton M, Brukner I, Longtin J, Loo VG, Dascal A, Longtin Y.

Clin Infect Dis. 2018 May 16. doi: 10.1093/cid/ciy425. [Epub ahead of print]

PMID:
29771298
2.

Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series Analysis.

Xiao Y, Paquet-Bolduc B, Garenc C, Gervais P, Trottier S, Roussy JF, Longtin J, Loo VG, Longtin Y.

Clin Infect Dis. 2018 Apr 17;66(9):1377-1382. doi: 10.1093/cid/cix1024.

PMID:
29149279
3.

Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Lévesque S, Ben-David D, Cloutier I, Loo VG.

JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.

PMID:
27111806
4.

The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis.

Spring K, Fournier P, Lapointe L, Chabot C, Roussy J, Pommey S, Stagg J, Royal I.

Oncogene. 2015 Oct 29;34(44):5536-47. doi: 10.1038/onc.2015.9. Epub 2015 Mar 16.

PMID:
25772245
5.

Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines.

Roussy JP, Bessette L, Bernatsky S, Rahme E, Lachaine J.

Calcif Tissue Int. 2014 Jul;95(1):8-18. doi: 10.1007/s00223-014-9856-5. Epub 2014 Apr 16.

PMID:
24736884
6.

Human metapneumovirus viral load is an important risk factor for disease severity in young children.

Roussy JF, Carbonneau J, Ouakki M, Papenburg J, Hamelin MÈ, De Serres G, Boivin G.

J Clin Virol. 2014 Jun;60(2):133-40. doi: 10.1016/j.jcv.2014.03.001. Epub 2014 Mar 12.

PMID:
24686044
7.

Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis.

Roussy JF, Abed Y, Bouhy X, Boivin G.

J Clin Microbiol. 2013 Dec;51(12):4234-6. doi: 10.1128/JCM.02659-13. Epub 2013 Oct 2.

8.

Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada.

Roussy JP, Bessette L, Rahme E, Bernatsky S, Légaré J, Lachaine J.

Rheumatol Int. 2013 Aug 20. [Epub ahead of print]

PMID:
23959574
9.

Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.

Roussy JP, Bessette L, Bernatsky S, Rahme E, Lachaine J.

Osteoporos Int. 2013 Sep;24(9):2483-92. doi: 10.1007/s00198-013-2321-x. Epub 2013 Mar 16.

PMID:
23504029
10.

Mortality and readmission rates after hospitalization for upper and lower gastrointestinal events in Quebec, Canada.

Rahme E, Roussy JP, Woolcott J, Nedjar H, Barkun A.

J Clin Gastroenterol. 2013 Aug;47(7):586-92. doi: 10.1097/MCG.0b013e318282a1d7.

PMID:
23426460
11.

Gastrointestinal Mucormycosis following a Streptococcus pyogenes Toxic Shock Syndrome in a Previously Healthy Patient: A Case Report.

Roussy JF, Allard C, St-Germain G, Pépin J.

Case Rep Infect Dis. 2012;2012:476719. doi: 10.1155/2012/476719. Epub 2012 Jul 30.

12.

Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?

Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pépin J.

Eur Urol. 2012 Sep;62(3):453-9. doi: 10.1016/j.eururo.2012.04.044. Epub 2012 May 3.

PMID:
22575912
13.

Concordance with guideline recommendations: previous and more recent nonsteroidal anti-inflammatory drug prescriptions in Quebec, Canada.

Rahme E, Roussy JP, Lafrance JP, Nedjar H, Morin S.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):420-7. doi: 10.1002/pds.2339. Epub 2012 Jan 4.

PMID:
22223535
14.

Use of nonsteroidal antiinflammatory drugs: is there a change in patient risk profile after withdrawal of rofecoxib?

Rahme E, Roussy JP, Lafrance JP, Nedjar H, Morin S.

J Rheumatol. 2011 Feb;38(2):195-202. doi: 10.3899/jrheum.100332. Epub 2010 Nov 15. Review.

PMID:
21078717
15.

Proven infection-related sepsis induces a differential stress response early after ICU admission.

Lesur O, Roussy JF, Chagnon F, Gallo-Payet N, Dumaine R, Sarret P, Chraibi A, Chouinard L, Hogue B.

Crit Care. 2010;14(4):R131. doi: 10.1186/cc9102. Epub 2010 Jul 9.

16.

Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis.

McIntyre RS, Cragin L, Sorensen S, Naci H, Baker T, Roussy JP.

J Eval Clin Pract. 2010 Aug;16(4):744-55. doi: 10.1111/j.1365-2753.2009.01189.x. Epub 2010 Jun 10.

PMID:
20545800
17.

Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective.

Bessette L, Risebrough N, Mittmann N, Roussy JP, Ho J, Zlateva G.

J Med Econ. 2009 Sep;12(3):246-58. doi: 10.3111/13696990903288970.

PMID:
19743942
18.

Cost of corneal transplantation for the Quebec health care system.

Roussy JP, Aubin MJ, Brunette I, Lachaine J.

Can J Ophthalmol. 2009 Feb;44(1):36-41. doi: 10.3129/i08-180.

PMID:
19169311
19.

Mercury sorption on a thiocarbamoyl derivative of chitosan.

Gavilan KC, Pestov AV, Garcia HM, Yatluk Y, Roussy J, Guibal E.

J Hazard Mater. 2009 Jun 15;165(1-3):415-26. doi: 10.1016/j.jhazmat.2008.10.005. Epub 2008 Oct 14.

PMID:
19059716
20.

Influence of chitosan characteristics on the coagulation and the flocculation of bentonite suspensions.

Roussy J, Van Vooren M, Dempsey BA, Guibal E.

Water Res. 2005 Sep;39(14):3247-58.

PMID:
16019052
21.

[Trisomy 9p. A case of translocation t(9;22) (p11;p11)mat in a little girl].

Genest P, Roussy J, Genest FB, Dumas L.

Union Med Can. 1977 Jul;106(7):956-9. French. No abstract available.

PMID:
898406
22.

Study of the factors regulating the disposal of repeated glucose injections.

Verdy M, Roussy J, Tetreault L, Leboeuf G.

Metabolism. 1971 Mar;20(3):273-7. No abstract available.

PMID:
5546923
23.

[Systematized condensing osteopathies].

LEDOUX-LEBARD G, ROUSSY J, LAURENT YM.

Prog Med (Paris). 1961 Apr 10-24;89:143-53. French. No abstract available.

PMID:
13760201
24.

[Osteopecillia].

LEDOUX-LEBARD G, ROUSSY J.

Presse Med. 1961 Feb 4;69:235-8. French. No abstract available.

PMID:
13760202
25.

[Radiological aspects of bony extremities in leprosy].

ROUSSY J.

Maroc Med. 1957 Nov;36(390):1163-76. French. No abstract available.

PMID:
13515632
26.

[Comparison of the activity of the anti-cancerous centers in Algeria & Casablanca].

FOURNIER H, ROUSSY J.

Maroc Med. 1957 Aug;36(387):748-50. French. No abstract available.

PMID:
13482437
27.

[Treatment of cancer of skin].

FOURNIER H, ROUSSY J.

Maroc Med. 1956 Sep;35(376):860-3. French. No abstract available.

PMID:
13368716
28.

La lutte contre le cancer au Maroc.

FOURNIER H, ROUSSY J.

Maroc Med. 1956 Jun;35(373):575-81. French. No abstract available.

PMID:
13368667
29.

[Atypical localization of a diffuse lipoma of the left side of the face and neck].

AGOSTINI M, FOURNIER H, ROUSSY J, SARROLA A, GROZES Y.

Maroc Med. 1956 Mar;35(370):247. French. No abstract available.

PMID:
13333297
30.

[A case of exostoses disease].

FOURNIER H, CHENEBAULT J, LE PAPE J, ROUSSY J.

Maroc Med. 1956 Jan;35(368):39-44. French. No abstract available.

PMID:
13321139

Supplemental Content

Loading ...
Support Center